Vivek Misra
Overview
Explore the profile of Vivek Misra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
791
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Is early-onset colorectal cancer an evolving pandemic? Real-world data from a tertiary cancer center
Angelakas A, Christodoulou T, Kamposioras K, Barriuso J, Braun M, Hasan J, et al.
Oncologist
. 2024 Oct;
29(12):e1680-e1691.
PMID: 39359067
Background: Early onset Colorectal Cancer (EOCRC), defined as those diagnosed under the age of 50, has been increasing rapidly since 1970. UK data on EOCRC are currently limited and better...
2.
Potter T, Tannous J, Pan A, Bako A, Johnson C, Baig E, et al.
Front Neurol
. 2023 Jun;
14:1176924.
PMID: 37384280
Background: Socioeconomic deprivation drives poor functional outcomes after intracerebral hemorrhage (ICH). Stroke severity and background cerebral small vessel disease (CSVD) burden have each been linked to socioeconomic status and independently...
3.
Kenny L, Beresford M, Brown I, Misra V, Kristeleit H
Eur J Cancer Care (Engl)
. 2022 Nov;
31(6):e13747.
PMID: 36336468
Objective: Eribulin treatment improved overall survival with predictable toxicities in phase 3 trials of patients with previously treated, locally advanced/metastatic breast cancer. This study (NCT02443428) prospectively observed eribulin-treated patients in...
4.
Jafri M, Kristeleit H, Misra V, Baxter M, Ahmed S, Jegannathen A, et al.
Oncology
. 2022 Aug;
100(12):666-673.
PMID: 36044833
Introduction: This study examined real-world data from patients who received eribulin for metastatic breast cancer (MBC) collected from 14 hospitals across the UK. Methods: Anonymized data were collected retrospectively from...
5.
Stringer J, Ryder W, Mackereth P, Misra V, Wardley A
Eur J Oncol Nurs
. 2022 Aug;
60:102171.
PMID: 35952460
Purpose: Chemotherapy-induced peripheral neuropathy (CIPN) is a dose limiting toxicity posing a major clinical challenge for managing patients receiving specific chemotherapy regimens (e.g., Taxanes). There is a growing body of...
6.
Hoskin P, Hopkins K, Misra V, Holt T, McMenemin R, McKinna F, et al.
Radiother Oncol
. 2022 May;
173:77-83.
PMID: 35618101
Background: Metastatic spinal cord compression (MSCC) carries a poor prognosis and management is based on the likelihood of maintaining mobility and predicted survival. Patients And Method: SCORAD is a randomised...
7.
Coe F, Misra V, McCabe Y, Adderley H, Woodhouse L, Ayub Z, et al.
Breast Cancer Res Treat
. 2021 Nov;
191(3):535-543.
PMID: 34843027
Purpose: The aim of this study was to identify factors associated with progression-free survival (PFS) and overall survival (OS) in patients with metastatic breast cancer (MBC) treated with eribulin in...
8.
Sadaf H, Desai V, Misra V, Golanov E, Hegde M, Villapol S, et al.
Ann Clin Transl Neurol
. 2021 Oct;
8(11):2211-2221.
PMID: 34647437
Intracerebral hemorrhage (ICH) remains a common and debilitating form of stroke. This neurological emergency must be diagnosed and treated rapidly yet effectively. In this article, we review the medical, surgical,...
9.
Grotta J, Yamal J, Parker S, Rajan S, Gonzales N, Jones W, et al.
N Engl J Med
. 2021 Sep;
385(11):971-981.
PMID: 34496173
Background: Mobile stroke units (MSUs) are ambulances with staff and a computed tomographic scanner that may enable faster treatment with tissue plasminogen activator (t-PA) than standard management by emergency medical...
10.
Gowda S M, Kabeer K, Jafferbhoy S, Marla S, Soumian S, Misra V, et al.
Indian J Surg
. 2020 Aug;
82(3):251-258.
PMID: 32837081
The coronavirus disease (COVID-19) pandemic in 2020 has brought about complex challenges in healthcare delivery. With the new rules of lockdown and social distancing and with resources diverted to the...